Overview

Combination Chemotherapy in Treating Patients With Lymphoma

Status:
Completed
Trial end date:
2004-02-04
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of combination chemotherapy in treating patients who have intermediate-grade or immunoblastic lymphoma.
Phase:
Phase 3
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Bleomycin
Carmustine
Cisplatin
Cyclophosphamide
Cytarabine
Etoposide
Etoposide phosphate
Idarubicin
Ifosfamide
Interferon-alpha
Interferons
Isophosphamide mustard
Lenograstim
Leucovorin
Levoleucovorin
Melphalan
Methotrexate
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Mitoxantrone
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Vincristine